Aeras and IDRI sign agreement to jointly develop novel tuberculosis vaccine

Aeras and the Infectious Disease Research Institute (IDRI) announce today a new agreement to conduct joint development activities with respect to IDRI's novel tuberculosis vaccine candidate. This collaboration reflects the missions of the two non-profit product development partnerships to use cutting-edge science to develop products that address critical diseases of under-served populations around the world, including tuberculosis. Read more